Net profit of Gennex Laboratories rose 61.21% to Rs 3.74 crore in the quarter ended March 2026 as against Rs 2.32 crore during the previous quarter ended March 2025. Sales rose 51.15% to Rs 60.96 crore in the quarter ended March 2026 as against Rs 40.33 crore during the previous quarter ended March 2025.
For the full year,net profit rose 14.52% to Rs 18.46 crore in the year ended March 2026 as against Rs 16.12 crore during the previous year ended March 2025. Sales rose 25.26% to Rs 172.74 crore in the year ended March 2026 as against Rs 137.90 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 60.96 | 40.33 | 51 | 172.74 | 137.90 | 25 |
| OPM % | 9.65 | 5.01 | - | 12.98 | 19.69 | - |
| PBDT | 6.13 | 4.65 | 32 | 26.49 | 23.54 | 13 |
| PBT | 4.97 | 4.10 | 21 | 23.84 | 21.55 | 11 |
| NP | 3.74 | 2.32 | 61 | 18.46 | 16.12 | 15 |
Powered by Capital Market - Live News
